Galena Biopharma, Inc. (GALE):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Galena Biopharma, Inc. (GALE) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH82624FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,300見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥66,600見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥99,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Galena Biopharma, Inc. (Galena) is a biotechnology company. The company discovers, develops and commercializes therapies for the treatment of unmet medical needs, and advance care. Its products include Abstral, NeuVax, NeuVax Herceptin, and folate binding protein. The company provides NeuVax and NeuVax Hercepti for the treatment of breast cancer and folate binding protein for the treatment of endometrial and ovarian cancer. Galena’s Abstral is a sublingual tablets for the management of breakthrough pain in cancer patients of 18 years of age. It partners with academia, small companies, and large multinationals. Galena is headquartered in Lake Portland, Oregon, the US.

Galena Biopharma, Inc. Key Recent Developments

Dec 04, 2013: Galena Biopharma to Present at the Oppenheimer 24th Annual Healthcare Conference
Nov 26, 2013: Galena Biopharma to present at the 25th annual Piper Jaffray Healthcare Conference
Nov 06, 2013: Galena Biopharma Reports Third Quarter 2013 Results
Oct 04, 2013: Galena Biopharma to Present at the 12th Annual BIO Investor Forum
Sep 23, 2013: Galena Biopharma to Present at the 20th Annual NewsMakers in the Biotech Industry Conference

This comprehensive SWOT profile of Galena Biopharma, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Galena Biopharma, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Galena Biopharma, Inc. – Key Information
Galena Biopharma, Inc. – Overview
Galena Biopharma, Inc. – Key Employees
Galena Biopharma, Inc. – Key Employee Biographies
Galena Biopharma, Inc. – Key Operational Heads
Galena Biopharma, Inc. – Major Products and Services
Galena Biopharma, Inc. – History
Galena Biopharma, Inc. – Company Statement
Galena Biopharma, Inc. – Locations And Subsidiaries
Galena Biopharma, Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Galena Biopharma, Inc. – Business Description
Galena Biopharma, Inc. – Corporate Strategy
Galena Biopharma, Inc. – SWOT Analysis
SWOT Analysis – Overview
Galena Biopharma, Inc. – Strengths
Galena Biopharma, Inc. – Weaknesses
Galena Biopharma, Inc. – Opportunities
Galena Biopharma, Inc. – Threats
Galena Biopharma, Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

Galena Biopharma, Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Galena Biopharma, Inc., Key Information
Galena Biopharma, Inc., Key Ratios
Galena Biopharma, Inc., Share Data
Galena Biopharma, Inc., Major Products and Services
Galena Biopharma, Inc., History
Galena Biopharma, Inc., Key Employees
Galena Biopharma, Inc., Key Employee Biographies
Galena Biopharma, Inc., Key Operational Heads
Galena Biopharma, Inc., Other Locations
Galena Biopharma, Inc., Subsidiaries
Galena Biopharma, Inc., Key Manufacturing facilities
Galena Biopharma, Inc., Key Competitors
Galena Biopharma, Inc., SWOT Analysis
Galena Biopharma, Inc., Ratios based on current share price
Galena Biopharma, Inc., Annual Ratios
Galena Biopharma, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Galena Biopharma, Inc., Performance Chart
Galena Biopharma, Inc., Ratio Charts

★海外企業調査レポート[Galena Biopharma, Inc. (GALE):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Yanchang Petroleum International Ltd (346):企業の財務・戦略的SWOT分析
    Yanchang Petroleum International Ltd (346) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Casual Dining Group:企業の戦略・SWOT・財務分析
    SummaryCasual Dining Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fin …
  • China Petroleum and Chemical Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' China Petroleum and Chemical Co …
  • Hemisphere Energy Corporation (HME):企業概要、財務及び戦略的SWOT分析
    Summary Hemisphere Energy Corporation (Hemisphere) is an oil and gas company. The company explores, develops, and produces oil and natural gas in the North America. Its operations consist of heavy oil assets in the Jenner area of southeast Alberta and liquids rich natural gas assets in the Trutch ar …
  • Radiant Innovation Inc. (3373):企業概要、財務及び戦略的SWOT分析
    Summary Radiant Innovation Inc. (Radiant) is a medical device manufacturer. The company designs and develops medical infrared technology products. It offers product through three product lines such as Radiant, medical infrared thermometers; ZyTemp, industrial use and wide-range infrared thermometers …
  • Emaar Properties PJSC:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Emaar Properties PJSC" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. World Market Intellig …
  • Johnson & Johnson (JNJ)-製薬・医療分野:企業M&A・提携分析
    Summary Johnson & Johnson (J&J) engages in the research and development, manufacture and sale of a range of healthcare products. Its primary focus is on the development of products related to human health and well-being. The company provides pharmaceuticals in immunology, cancer, neuroscience, infec …
  • MTY Food Group Inc.:戦略・SWOT・企業財務分析
    MTY Food Group Inc. - Strategy, SWOT and Corporate Finance Report Summary MTY Food Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Osprey Medical, Inc. (OSP):企業の財務及び戦略的SWOT分析
    Summary Osprey Medical, Inc. (Osprey Medical) is a medical device company that develops and commercializes products for the prevention of contrast induced nephropathy. The company’s avert system is a dye reduction system, which provides cardiologists with CIN protection in high risk patients undergo …
  • Medivir AB:企業のM&A・提携・投資分析
    Medivir AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Medivir AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Median Technologies SA (ALMDT):企業財務及び戦略的SWOT分析
    Summary Median Technologies SA (Median) is a medical device company that offers medical imaging products and services. The company offers software medical devices. Its services comprise imaging services for CT, companion and monitoring tests; managed services and investigator site network services. …
  • Tampa Electric Co:発電所・企業SWOT分析
    Tampa Electric Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Wah Hong Industrial Corp (8240):企業の財務及び戦略的SWOT分析
    Summary Wah Hong Industrial Corp (WHIC) is a chemical company that develops, manufactures and markets composite materials and advanced plastics. The company was formerly known as Wah Hong Chemical Corp. It offers products such as optical film, sheet for LCD uses, BMC compounds, bulk molding products …
  • Orascom Construction Industries Companyの企業概要及び財務/SWOT分析
    Orascom Construction Industries Company Fundamental Company Report is an absolutely essential resource for anyone looking for detailed information on the above-mentioned company. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about Orascom …
  • Merro Pharmaceutical Co Ltd:企業のM&A・提携動向(医療分野)
    Summary Merro Pharmaceutical Co Ltd (Merro Pharma) is a pharmaceutical products manufacturer that discovers, develops, manufactures, sells and markets chemical medicine. The company provides biological medicine, Chinese traditional medicine and herbal medicine. Its products include amifostine, roxit …
  • Netmedia S.A.:企業の戦略・SWOT・財務分析
    SummaryNetmedia S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • RTI Surgical Inc (RTIX)-医療機器分野:企業M&A・提携分析
    Summary RTI Surgical Inc (RTI), formerly RTI Biologics Inc is a surgical implant company that offers biologic, metal and synthetic implants. The company’s products include spine implants, surgical specialties, sports medicine implants, cardiothoracic and orthobiologics. It offers spine implants such …
  • Fairstar Resources Limited (FAS):企業概要、財務及び戦略的SWOT分析
    Summary Fairstar Resources Limited (Fairstar Resources) is a mineral exploration company. The company acquires, explores and produces mineral resource such as gold, base metals, uranium and iron ores. Its projects include Steeple Hill Iron Project, Kurnalpi-Randalls, Mount Padbury, Spinifex Well, Mi …
  • Byte Computer SA (BYTE):企業財務及び戦略的SWOT分析
    Summary Byte Computer SA (Byte) is an information technology and communications integrator that designs, develops, implements business solutions. The company’s solutions include virtualization, security, cloud computing, storage and data, network and communications, business productivity, mobility, …
  • PT Multiintegra:企業の戦略・SWOT・財務分析
    SummaryPT Multiintegra - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Finding …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆